Orchestra BioMed founded in 2017 out of New Hope, Penn. is a biomedical company that brings high-impact medical technology to patients through collaboration and risk-reward partnerships, according to a June 29 press release.
Three takeaways from the collaboration:
- Orchestra BioMed and Medtronic will partner to develop a potential treatment for patients with hypertension who have a cardiac pacemaker.
- The $110 million in financing is managed by RTW Investments, Perspective Advisors, Terumo, SternAegis Ventures and others.
- Orchestra BioMed now has enough capital that it expects to be able to fund operations into 2026.
Latest articles on healthcare information technology:
Graphite Health hires Baylor Scott & White Health’s chief legal officer
16 recent health IT innovations, partnerships
Tampa General Hospital launches home-based healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
